Merck & Co Inc MRK:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

Last | 05/14/24 EDT

131.73UNCH (UNCH)

Volume

6,839,919

52 week range

99.14 - 133.10

Open128.88
Day High131.96
Day Low128.72
Prev Close131.73
52 Week High133.10
52 Week High Date03/27/24
52 Week Low99.14
52 Week Low Date10/19/23

Key Stats

Market Cap333.647B
Shares Out2.53B
10 Day Average Volume6.76M
Dividend3.08
Dividend Yield2.34%
Beta0.41
YTD % Change20.83

KEY STATS

Open128.88
Day High131.96
Day Low128.72
Prev Close131.73
52 Week High133.10
52 Week High Date03/27/24
52 Week Low99.14
52 Week Low Date10/19/23
Market Cap333.647B
Shares Out2.53B
10 Day Average Volume6.76M
Dividend3.08
Dividend Yield2.34%
Beta0.41
YTD % Change20.83

RATIOS/PROFITABILITY

EPS (TTM)0.89
P/E (TTM)147.66
Fwd P/E (NTM)15.57
EBITDA (TTM)11.979B
ROE (TTM)5.29%
Revenue (TTM)61.402B
Gross Margin (TTM)74.85%
Net Margin (TTM)3.78%
Debt To Equity (MRQ)84.78%

EVENTS

Earnings Date07/30/2024(est)
Ex Div Date03/14/2024
Div Amount0.77
Split Date-
Split Factor-

Latest On Merck & Co Inc

Trade Tracker: Joe Terranova buys Amgen and Merck14 Hours AgoCNBC.com
Cramer: Patience in Wynn will be rewarded after surprise post-earnings dropMay 8, 2024CNBC.com
Cramer explains how to maintain a balanced portfolio as the economy slowsMay 7, 2024CNBC.com
Lilly assures investors it can overcome the high-quality problem of too much demandApril 30, 2024CNBC.com
Cramer: 5 sectors of the market that are working and stocks that stand out in eachApril 28, 2024CNBC.com

Content From Our Affiliates

Analysts Are Bullish on Top Healthcare Stocks: Merck & Company (MRK), Inovio Pharmaceuticals (INO)May 14, 2024TipRanks
Merck discontinues vibostolimab-Keytruda combination arm of Phase 3 trialMay 13, 2024TipRanks
Merck provides update on Phase 3 KEYNOTE-B21 trialMay 9, 2024TipRanks
CytomX Therapeutics, Merck enter CX-801 trial collaborationMay 7, 2024TipRanks
Merck: KEYNOTE-811 trial meets dual primary endpoint of OSMay 1, 2024TipRanks

Profile

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical...

Robert Davis

Chairman of the Board, President, Chief Executive Officer

Caroline Litchfield

Chief Financial Officer, Executive Vice President

Sanat Chattopadhyay

Executive Vice President and President - Merck Manufacturing Division

Dean Li M.D., Ph.D.

Executive Vice President, President - Merck Research Laboratories

Cristal Downing

Executive Vice President, Chief Communications and Public Affairs Officer

Address

126 East Lincoln Avenue

Rahway, NJ

07065

United States

https://www.merck.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ABBV AbbVie Inc	163.79	UNCH	UNCH
JNJ Johnson & Johnson	152.67	UNCH	UNCH
AZN AstraZeneca PLC	76.97	UNCH	UNCH
NVS Novartis AG	103.22	UNCH	UNCH
RHHBY Roche Holding AG	31.40	+0.45	+1.45%